Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients

Aim of this study was to evaluate the efficacy and the safety of switching from branded to generic antiretrovirals in patients with HIV-RNA

Saved in:
Bibliographic Details
Published in:PloS one 2017-08, Vol.12 (8), p.e0182007
Main Authors: Gianotti, Nicola, Poli, Andrea, Galli, Laura, Franzin, Michela, Tadini, Patrizia, Galizzi, Nadia, Carbone, Alessia, Merli, Marco, Muccini, Camilla, Oltolini, Chiara, Andolina, Andrea, Spagnuolo, Vincenzo, Lazzarin, Adriano, Castagna, Antonella
Format: Article
Language:English
Subjects:
Acquired immune deficiency syndrome
AIDS
Analysis
Anti-HIV Agents - therapeutic use
Antibodies
Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Antiviral agents
Benzoxazines - therapeutic use
Biology and Life Sciences
Care and treatment
CD4 antigen
Cohort Studies
Complications and side effects
Dideoxynucleosides - therapeutic use
Dosage and administration
Drug Combinations
Drug therapy
Drug Therapy, Combination
Drugs, Generic - therapeutic use
Efavirenz
Effectiveness
Female
Follow-Up Studies
Generic drugs
HIV
HIV infections
HIV Infections - drug therapy
HIV-1
Human immunodeficiency virus
Humans
Iridium
Lamivudine
Lamivudine - therapeutic use
Male
Medical diagnosis
Medicine and Health Sciences
Middle Aged
Patient Safety
Patients
Poisson Distribution
Ribonucleic acid
RNA
RNA, Viral
Safety
Social Sciences
Toxicity
Treatment Outcome
Zidovudine
Zidovudine - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim of this study was to evaluate the efficacy and the safety of switching from branded to generic antiretrovirals in patients with HIV-RNA
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0182007